BioCentury
ARTICLE | Clinical News

Eniluracil: Phase II started

April 11, 2011 7:00 AM UTC

Adherex began the open-label, international Phase II (AHX-03-202) trial in about 140 patients to compare 40 mg oral eniluracil weekly for the first 3 weeks of a 4-week cycle plus 5-fluorouracil (5-FU)...